Clinical Trials

Adenocarcinoma, Stomach Neoplasms

NCT07431281 2026-05-27

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Phase 3 Recruiting

2,130 enrolled

Phase 2 Not yet recruiting

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT07574541 2026-05-27

Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance

52 enrolled

Phase 3 Active not recruiting

Adenocarcinoma, Carcinoma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Prostatic Neoplasms

NCT05581121 2026-05-26

PAROLA

Phase 3 Recruiting

510 enrolled

Gynecologic

Adenocarcinoma, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

NCT00923026 2026-05-22

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

Enrolling by invitation

1,150 enrolled

DermatologicEndocrineNET

Adenocarcinoma, Carcinoma, Melanoma, Neuroendocrine Tumors

NCT06564844 2026-05-22

TROPION-Lung12

25 enrolled

Phase NA Not yet recruiting

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT07489820 2026-05-22

AAPICO

100 enrolled

Phase 3 Not yet recruiting

Adenocarcinoma

NCT07598032 2026-05-20

iCCaRE

200 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07196488 2026-05-19

Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses

60 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT00911118 2026-05-18

Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer

Phase 1 Completed

120 enrolled

Phase 1 Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07316686 2026-05-18

Lutécio

18 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07541911 2026-05-18

LaserSAFE

693 enrolled

Phase 2 Not yet recruiting

Margins of Excision, Adenocarcinoma, Prostatic Neoplasms

NCT07592910 2026-05-18

MOMENT

60 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT06807398 2026-05-15

RF-2018-123683

Completed

367 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT06862856 2026-05-15

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

Recruiting

50 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT02133196 2026-05-13

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

85 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Neoplasm Metastasis, Carcinoma, Adenosquamous

NCT04379596 2026-05-13

DG-03

450 enrolled

Phase 2 Active not recruiting

Adenocarcinoma, Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT05208944 2026-05-13

THIO Sequenced With Cemiplimab in Advanced NSCLC

227 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

NCT07237399 2026-05-13

TA-P-OLIM

Withdrawn

Adenocarcinoma, Prostatic Neoplasms

NCT03415854 2026-05-12

NABPLAGEMD

34 enrolled 11 charts

Adenocarcinoma, Pancreatic Neoplasms

NCT05672524 2026-05-12

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

37 enrolled

Adenocarcinoma, Rectal Neoplasms

NCT05968326 2026-05-11

IMCODE003

260 enrolled

Adenocarcinoma

NCT06794073 2026-05-11

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

17 enrolled

Phase 1 Active not recruiting

Adenocarcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms, Glandular and Epithelial

NCT04627246 2026-05-08

Personalized Vaccine With SOC Chemo Followed by Nivo in Pancreatic Cancer

14 enrolled

Phase 1 Active not recruiting

Adenocarcinoma, Neoplasms

NCT04644770 2026-05-08

A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer

144 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT04864067 2026-05-08

NOAHS-ARC

39 enrolled

Phase 1/2 Not yet recruiting

Adenocarcinoma, Rectal Neoplasms

NCT07529808 2026-05-08

ChefHat-001

164 enrolled

Phase 1 Active not recruiting

Adenocarcinoma, Colonic Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT03132922 2026-05-07

MAGE-A4ᶜ¹º³²T for Multi-Tumor

71 enrolled 20 charts

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Sarcoma, Synovial, Liposarcoma, Myxoid

NCT05922930 2026-05-06

Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer

Phase 1/2 Recruiting

51 enrolled

GastrointestinalGynecologic

Adenocarcinoma, Ovarian Neoplasms, Pancreatic Neoplasms

NCT06205836 2026-05-06

Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer

44 enrolled

Phase 2 Not yet recruiting

Adenocarcinoma, Carcinoma, Colorectal Neoplasms

NCT07281768 2026-05-06

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

66 enrolled

Adenocarcinoma, Carcinoma, Rectal Neoplasms, Colorectal Neoplasms

NCT07568444 2026-05-06

Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)

120 enrolled

GastrointestinalGynecologic

Adenocarcinoma, Urinary Bladder Neoplasms, Kidney Neoplasms, Prostatic Neoplasms, Testicular Neoplasms

NCT04034251 2026-05-05

Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis

Phase 2 Terminated

12 enrolled 18 charts

Adenocarcinoma, Peritoneal Neoplasms, Stomach Neoplasms

NCT05365581 2026-05-05

A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

Phase 1 Recruiting

398 enrolled

Phase 3 Active not recruiting

Adenocarcinoma

NCT03504397 2026-05-04

Spotlight

565 enrolled 63 charts 1 FDA

Phase 1 Enrolling by invitation

Adenocarcinoma, Neoplasms, Stomach Neoplasms

NCT07218003 2026-05-04

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

149 enrolled

BreastGastrointestinalGenitourinaryGynecologicThoracic

Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT07124000 2026-05-01

DP-04

Recruiting

100 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Adenocarcinoma, Anus Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Melanoma, Mouth Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gastrointestinal Stromal Tumors, Small Cell Lung Carcinoma

NCT06661044 2026-04-30

EVENTIDE

Completed

6 enrolled

Phase 2 Active not recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT05063565 2026-04-29

ROWAN

100 enrolled

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT06901531 2026-04-29

LUCERNA

Phase 3 Recruiting

500 enrolled

Phase NA Enrolling by invitation

Adenocarcinoma, Neoplasms

NCT00102544 2026-04-28

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

3,894 enrolled

Adenocarcinoma, Carcinoma, Renal Cell, von Hippel-Lindau Disease, Prostatic Neoplasms

NCT02664935 2026-04-28

National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer

423 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms

NCT05014776 2026-04-28

Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer

17 enrolled 8 charts

Adenocarcinoma, Carcinoma, Pancreatic Neoplasms

NCT06846346 2026-04-28

GRACIE

88 enrolled

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

NCT07439913 2026-04-27

Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer

Enrolling by invitation

120 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07552922 2026-04-27

DINGO

24 enrolled

Adenocarcinoma, Gynecomastia, Prostatic Neoplasms

NCT06844383 2026-04-24

TALENT

126 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07259317 2026-04-23

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

60 enrolled

Adenocarcinoma, Carcinoma, Pancreatic Ductal

NCT06561685 2026-04-20

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

340 enrolled